SmithKline Timentin
Executive Summary
Marketing of the injectable antibiotic Timentin (ticarcillin/clavulanate potassium) has resumed. Production of the product at the Piscataway, N.J., plant, was halted Jan. 26 because of sterility failures but resumed in June. U.S. sales of Timentin in 1998 were approximately $116 mil